Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Mayumi Nakagawa

Concepts (217)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Papillomavirus Infections
15
2024
155
4.800
 Why?
Human papillomavirus 16
11
2021
44
3.780
 Why?
Uterine Cervical Neoplasms
10
2024
274
3.520
 Why?
Papillomavirus Vaccines
7
2021
61
3.450
 Why?
Oncogene Proteins, Viral
11
2011
52
2.570
 Why?
Papillomaviridae
7
2019
102
2.430
 Why?
Repressor Proteins
9
2011
151
2.190
 Why?
Epitopes, T-Lymphocyte
7
2018
24
2.000
 Why?
Cancer Vaccines
3
2021
78
1.680
 Why?
T-Lymphocytes
6
2021
338
1.480
 Why?
Candida
4
2018
60
1.400
 Why?
CD8-Positive T-Lymphocytes
6
2018
115
1.370
 Why?
Cervix Uteri
3
2021
49
0.920
 Why?
Uterine Cervical Dysplasia
2
2015
49
0.870
 Why?
Immunity, Cellular
4
2013
69
0.770
 Why?
Lymphocytes, Tumor-Infiltrating
1
2021
76
0.750
 Why?
Epitopes
2
2015
59
0.740
 Why?
Langerhans Cells
3
2018
11
0.730
 Why?
Neoplasms
2
2021
1233
0.710
 Why?
Viral Load
2
2019
76
0.690
 Why?
Health Education
1
2021
156
0.680
 Why?
Cell Cycle Checkpoints
1
2019
32
0.670
 Why?
HLA Antigens
4
2006
51
0.650
 Why?
Colorectal Neoplasms
1
2021
234
0.620
 Why?
Adult
20
2021
13160
0.590
 Why?
CD4-Positive T-Lymphocytes
3
2018
163
0.590
 Why?
Humans
40
2024
49827
0.590
 Why?
Female
28
2024
26329
0.580
 Why?
Health Knowledge, Attitudes, Practice
1
2021
488
0.550
 Why?
Plasma Exchange
2
2014
23
0.540
 Why?
Cross Protection
1
2015
5
0.520
 Why?
T-Lymphocytes, Regulatory
2
2016
85
0.510
 Why?
Colposcopy
1
2015
18
0.500
 Why?
Interleukin-12
2
2018
31
0.500
 Why?
Adjuvants, Immunologic
2
2018
51
0.490
 Why?
Immunity, Innate
1
2015
104
0.480
 Why?
Interferon-gamma
2
2012
174
0.460
 Why?
Health
1
2013
25
0.460
 Why?
Lectins, C-Type
1
2013
30
0.460
 Why?
Papillomavirus E7 Proteins
8
2018
31
0.460
 Why?
Young Adult
9
2021
3936
0.450
 Why?
Patient Selection
1
2015
251
0.450
 Why?
Middle Aged
14
2021
11997
0.440
 Why?
Afibrinogenemia
1
2012
5
0.420
 Why?
Enzyme-Linked Immunospot Assay
1
2012
2
0.420
 Why?
T-Lymphocytes, Cytotoxic
4
2009
65
0.410
 Why?
Breast Neoplasms
1
2021
1169
0.410
 Why?
Vaginal Smears
3
2021
28
0.380
 Why?
Cell Proliferation
5
2021
1007
0.380
 Why?
Early Detection of Cancer
3
2021
165
0.380
 Why?
Warts
1
2010
13
0.380
 Why?
Plateletpheresis
1
2010
7
0.370
 Why?
Antigens, Fungal
1
2010
24
0.370
 Why?
Blood Preservation
1
2010
26
0.370
 Why?
Dermatitis
1
2010
36
0.370
 Why?
Blood Proteins
1
2010
82
0.360
 Why?
Anaphylaxis
1
2010
71
0.350
 Why?
Cells, Cultured
5
2021
1571
0.330
 Why?
Antigens, Viral
2
2009
44
0.320
 Why?
Telemedicine
1
2015
443
0.320
 Why?
Immunotherapy
1
2010
238
0.320
 Why?
Human papillomavirus 18
1
2008
9
0.320
 Why?
Blood Platelets
1
2010
245
0.310
 Why?
Host-Pathogen Interactions
2
2021
129
0.300
 Why?
Vaccinia virus
1
2007
6
0.290
 Why?
Dendritic Cells
1
2008
132
0.290
 Why?
Immunoenzyme Techniques
1
2007
143
0.280
 Why?
Immunophenotyping
1
2007
109
0.280
 Why?
Cell Line, Tumor
5
2021
1402
0.250
 Why?
Isoantibodies
1
2004
27
0.250
 Why?
Aged
9
2021
9272
0.240
 Why?
Neoplasm Grading
2
2021
123
0.240
 Why?
Lead
1
2004
33
0.240
 Why?
Infant, Very Low Birth Weight
1
2004
45
0.240
 Why?
Neutropenia
1
2004
117
0.230
 Why?
DNA, Viral
3
2011
133
0.230
 Why?
Oropharyngeal Neoplasms
1
2024
19
0.230
 Why?
Anus Neoplasms
1
2024
24
0.230
 Why?
Coinfection
1
2024
38
0.230
 Why?
Blood Transfusion
1
2004
121
0.220
 Why?
Penile Neoplasms
1
2024
45
0.220
 Why?
Adolescent
5
2021
6340
0.220
 Why?
High-Throughput Nucleotide Sequencing
2
2021
169
0.220
 Why?
Capsid Proteins
1
2002
24
0.210
 Why?
Antibody Formation
1
2002
56
0.210
 Why?
Clone Cells
3
2007
74
0.200
 Why?
Genes, T-Cell Receptor
1
2021
5
0.200
 Why?
Treatment Outcome
3
2021
5138
0.200
 Why?
Clinical Trials, Phase I as Topic
1
2021
25
0.200
 Why?
Cytokines
2
2016
612
0.200
 Why?
Pilot Projects
2
2021
699
0.190
 Why?
Remission Induction
1
2021
207
0.190
 Why?
Cystadenocarcinoma, Serous
1
2021
70
0.190
 Why?
Mass Screening
2
2021
351
0.190
 Why?
Left-Right Determination Factors
1
2020
1
0.190
 Why?
Nodal Protein
1
2020
3
0.190
 Why?
Videotape Recording
1
2021
28
0.190
 Why?
Lymphocyte Activation
1
2021
172
0.190
 Why?
Mammography
1
2021
96
0.190
 Why?
Amino Acid Sequence
3
2008
587
0.180
 Why?
Focus Groups
1
2021
188
0.180
 Why?
Enzyme-Linked Immunosorbent Assay
3
2010
245
0.170
 Why?
Male
10
2024
25093
0.170
 Why?
Metagenome
1
2019
41
0.170
 Why?
Feasibility Studies
1
2021
374
0.170
 Why?
Glioblastoma
1
2020
91
0.170
 Why?
Parenteral Nutrition
1
2019
27
0.170
 Why?
Dose-Response Relationship, Drug
2
2016
1374
0.160
 Why?
Up-Regulation
1
2020
450
0.160
 Why?
Health Behavior
1
2021
251
0.160
 Why?
Transplantation Conditioning
1
2019
83
0.160
 Why?
DNA
1
2021
545
0.150
 Why?
Time Factors
2
2021
2912
0.150
 Why?
Bacteria
1
2019
223
0.150
 Why?
Leukocytes, Mononuclear
2
2016
116
0.150
 Why?
HLA-B Antigens
2
2008
6
0.150
 Why?
Multiple Myeloma
1
2012
2910
0.150
 Why?
Age Factors
1
2021
1090
0.150
 Why?
Cell Line
2
2012
1002
0.150
 Why?
Ovarian Neoplasms
1
2021
448
0.140
 Why?
Brain Neoplasms
1
2020
286
0.140
 Why?
Histocompatibility Antigens Class II
2
2008
37
0.140
 Why?
Head and Neck Neoplasms
1
2019
268
0.140
 Why?
Vaccines, Subunit
1
2016
15
0.140
 Why?
Body Mass Index
1
2019
652
0.130
 Why?
Molecular Sequence Data
2
2008
797
0.130
 Why?
Adaptive Immunity
1
2015
31
0.130
 Why?
Chromatography, Liquid
1
2016
232
0.120
 Why?
Leukocyte Count
2
2004
70
0.120
 Why?
Peptides
2
2006
222
0.120
 Why?
Tandem Mass Spectrometry
1
2016
236
0.120
 Why?
Factor VIII
1
2014
23
0.120
 Why?
Purpura, Thrombotic Thrombocytopenic
1
2014
15
0.120
 Why?
ADAM Proteins
1
2014
20
0.120
 Why?
Proteome
1
2016
173
0.120
 Why?
Mannose-Binding Lectins
1
2013
7
0.120
 Why?
Antigens, CD1
1
2013
9
0.120
 Why?
Receptors, Pattern Recognition
1
2013
4
0.120
 Why?
Indicators and Reagents
1
2013
36
0.120
 Why?
Vaccination
1
2016
268
0.120
 Why?
Intracellular Space
1
2013
25
0.120
 Why?
Skin Tests
1
2013
58
0.120
 Why?
Hematopoietic Stem Cell Transplantation
1
2019
553
0.120
 Why?
Cadherins
1
2013
68
0.110
 Why?
Proteomics
1
2016
328
0.110
 Why?
Communication
1
2015
244
0.110
 Why?
Rural Health Services
1
2015
164
0.110
 Why?
Research Design
1
2015
343
0.110
 Why?
Antigens, CD
1
2013
215
0.100
 Why?
Socioeconomic Factors
1
2015
580
0.100
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
595
0.100
 Why?
Longitudinal Studies
2
2005
673
0.100
 Why?
Injections, Intralesional
1
2010
31
0.090
 Why?
Isotonic Solutions
1
2010
19
0.090
 Why?
Platelet Transfusion
1
2010
28
0.090
 Why?
P-Selectin
1
2010
32
0.090
 Why?
Sodium Chloride
1
2010
57
0.090
 Why?
Platelet Aggregation
1
2010
71
0.090
 Why?
Platelet Activation
1
2010
46
0.090
 Why?
Hypersensitivity
1
2010
77
0.090
 Why?
Retrospective Studies
3
2019
6117
0.080
 Why?
Polymerase Chain Reaction
1
2010
455
0.080
 Why?
HLA-A Antigens
1
2008
10
0.080
 Why?
Antigen Presentation
1
2008
25
0.080
 Why?
Immunologic Memory
1
2008
30
0.080
 Why?
Histocompatibility Antigens Class I
1
2008
44
0.080
 Why?
Signal Transduction
2
2020
1617
0.080
 Why?
DNA, Recombinant
1
2007
15
0.070
 Why?
Animals
2
2019
13150
0.070
 Why?
Genes, MHC Class I
1
2006
11
0.070
 Why?
Arkansas
1
2013
1967
0.070
 Why?
Binding, Competitive
1
2006
95
0.070
 Why?
Neoplasm Staging
1
2008
746
0.060
 Why?
Calgranulin B
1
2005
4
0.060
 Why?
Calgranulin A
1
2005
5
0.060
 Why?
Immunomagnetic Separation
1
2004
7
0.060
 Why?
Epitope Mapping
1
2004
6
0.060
 Why?
Risk Factors
1
2013
3619
0.060
 Why?
Phosphorylation
2
2020
536
0.060
 Why?
Sensitivity and Specificity
1
2005
854
0.050
 Why?
Tumor Virus Infections
1
2002
43
0.050
 Why?
Antibodies, Viral
1
2002
88
0.050
 Why?
Lactobacillus
1
2021
7
0.050
 Why?
Immunoglobulin G
1
2002
186
0.050
 Why?
SOX Transcription Factors
1
2021
4
0.050
 Why?
Neuroendocrine Cells
1
2021
10
0.050
 Why?
Biological Specimen Banks
1
2021
21
0.050
 Why?
Cytodiagnosis
1
2021
42
0.050
 Why?
Cytoplasm
1
2021
90
0.050
 Why?
Cobalt
1
2020
15
0.050
 Why?
Recurrence
1
2002
651
0.050
 Why?
Vulnerable Populations
1
2020
45
0.050
 Why?
Epithelial-Mesenchymal Transition
1
2020
47
0.050
 Why?
Cohort Studies
1
2004
1422
0.050
 Why?
Cell Hypoxia
1
2020
82
0.050
 Why?
Neoplastic Stem Cells
1
2021
103
0.040
 Why?
Cell Movement
1
2021
247
0.040
 Why?
Community Health Workers
1
2020
43
0.040
 Why?
Multivariate Analysis
1
2021
585
0.040
 Why?
Parenteral Nutrition, Total
1
2019
31
0.040
 Why?
Sequence Analysis, DNA
1
2019
237
0.040
 Why?
Cell Survival
1
2020
598
0.040
 Why?
Phenotype
1
2021
727
0.040
 Why?
Cell Differentiation
1
2021
653
0.040
 Why?
Linear Models
1
2019
281
0.040
 Why?
Immunity, Humoral
1
2018
22
0.040
 Why?
Models, Biological
1
2021
728
0.040
 Why?
Infant, Newborn
1
2004
2744
0.040
 Why?
Gene Expression Regulation, Neoplastic
1
2020
829
0.030
 Why?
Prognosis
1
2021
1952
0.030
 Why?
Autoantibodies
1
2014
116
0.030
 Why?
Immunosuppressive Agents
1
2014
220
0.030
 Why?
Mice, Inbred C57BL
1
2018
1806
0.030
 Why?
Combined Modality Therapy
1
2014
636
0.030
 Why?
Mice
1
2018
5720
0.020
 Why?
Casein Kinase II
1
2005
10
0.020
 Why?
Cell Division
1
2005
292
0.010
 Why?
Nakagawa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (217) concept(s)
_
Co-Authors Expand Description
See all (26) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department